rdf:type |
|
lifeskim:mentions |
umls-concept:C0010583,
umls-concept:C0013216,
umls-concept:C0024305,
umls-concept:C0030705,
umls-concept:C0032952,
umls-concept:C0042679,
umls-concept:C0060483,
umls-concept:C0205282,
umls-concept:C0205390,
umls-concept:C0441771,
umls-concept:C1518321,
umls-concept:C1707455,
umls-concept:C2603343
|
pubmed:issue |
10
|
pubmed:dateCreated |
2006-3-31
|
pubmed:abstractText |
To compare the efficacy and safety of fludarabine phosphate with cyclophosphamide, vincristine, and prednisone (CVP) in 381 previously untreated, advanced-stage, low-grade (lg) non-Hodgkin's lymphoma (NHL) patients in a phase III, multicenter study.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1527-7755
|
pubmed:author |
pubmed-author:EghbaliHouchingueH,
pubmed-author:HagenbeekAntonA,
pubmed-author:HoskinPeter JPJ,
pubmed-author:KalmusJoachimJ,
pubmed-author:MacLennanKenK,
pubmed-author:MarcusRobertR,
pubmed-author:MonfardiniSilvioS,
pubmed-author:NegroukAnastassiaA,
pubmed-author:SchottAstridA,
pubmed-author:Staab-RennerElviraE,
pubmed-author:TeodorovicIvanaI,
pubmed-author:VitoloUmbertoU,
pubmed-author:de Wolf-PeetersChristianeC,
pubmed-author:van GlabbekeMartineM
|
pubmed:issnType |
Electronic
|
pubmed:day |
1
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1590-6
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16575010-Adult,
pubmed-meshheading:16575010-Aged,
pubmed-meshheading:16575010-Antimetabolites, Antineoplastic,
pubmed-meshheading:16575010-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:16575010-Cyclophosphamide,
pubmed-meshheading:16575010-Female,
pubmed-meshheading:16575010-Humans,
pubmed-meshheading:16575010-Lymphoma, Non-Hodgkin,
pubmed-meshheading:16575010-Male,
pubmed-meshheading:16575010-Middle Aged,
pubmed-meshheading:16575010-Neoplasm Staging,
pubmed-meshheading:16575010-Prednisone,
pubmed-meshheading:16575010-Prospective Studies,
pubmed-meshheading:16575010-Vidarabine Phosphate,
pubmed-meshheading:16575010-Vincristine
|
pubmed:year |
2006
|
pubmed:articleTitle |
Phase III intergroup study of fludarabine phosphate compared with cyclophosphamide, vincristine, and prednisone chemotherapy in newly diagnosed patients with stage III and IV low-grade malignant Non-Hodgkin's lymphoma.
|
pubmed:affiliation |
European Organisation for Research and Treatment of Cancer (EORTC) Lymphoma Group, Amsterdam, The Netherlands. a.hagenbeek@amc.uva.nl
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Clinical Trial, Phase III
|